Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Related Articles by Review for PubMed (Select 17192926)

1.

Financial anatomy of neuroscience research.

Dorsey ER, Vitticore P, De Roulet J, Thompson JP, Carrasco M, Johnston SC, Holloway RG, Moses H 3rd.

Ann Neurol. 2006 Dec;60(6):652-9. Review.

PMID:
17192926
2.

A new era in neuroscience.

[No authors listed]

Nat Neurosci. 2002 Nov;5 Suppl:1020-1. Review. No abstract available.

PMID:
12403974
3.

Patenting basic research: myths and realities.

Kirschenbaum SR.

Nat Neurosci. 2002 Nov;5 Suppl:1025-7. Review. No abstract available.

PMID:
12403976
4.

Industry-sponsored clinical research: a double-edged sword.

Montaner JS, O'Shaughnessy MV, Schechter MT.

Lancet. 2001 Dec 1;358(9296):1893-5. Review.

PMID:
11741648
5.

[The modeling of science: the example of North America].

MorĂ¡n-Mendoza AO.

Rev Invest Clin. 2004 Sep-Oct;56(5):665-74. Review. Spanish.

PMID:
15776871
6.

Pharmaceutical innovation in the 21st century: new drug approvals in the first decade, 2000-2009.

Kaitin KI, DiMasi JA.

Clin Pharmacol Ther. 2011 Feb;89(2):183-8. doi: 10.1038/clpt.2010.286. Epub 2010 Dec 29. Review.

PMID:
21191382
7.

Productivity shortfalls in drug discovery: contributions from the preclinical sciences?

Williams M.

J Pharmacol Exp Ther. 2011 Jan;336(1):3-8. doi: 10.1124/jpet.110.171751. Epub 2010 Aug 25. Review.

8.

The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration.

Vitiello B, Heiligenstein JH, Riddle MA, Greenhill LL, Fegert JM.

Biol Psychiatry. 2004 Jul 1;56(1):3-9. Review.

PMID:
15219466
9.

Medical research funding may have over-expanded and be due for collapse.

Charlton BG, Andras P.

QJM. 2005 Jan;98(1):53-5. Review.

10.

Biomedical research and the commercialization agenda: a review of main considerations for neuroscience.

Caulfield T, Ogbogu U.

Account Res. 2008 Oct-Dec;15(4):303-20. doi: 10.1080/08989620802388788. Review.

PMID:
18972268
11.

Bridging the Gap: establishing the necessary infrastructure and knowledge for teaching and research in neuroscience in Africa.

Yusuf S, Baden T, Prieto-Godino LL.

Metab Brain Dis. 2014 Jun;29(2):217-20. doi: 10.1007/s11011-013-9443-x. Epub 2013 Oct 30. Review.

PMID:
24166356
12.

Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry.

Privitera M.

Epilepsy Res. 2006 Jan;68(1):52-6. Review.

PMID:
16377139
13.

Ethics and social policy in research on the neuroscience of human sexuality.

Wolpe PR.

Nat Neurosci. 2004 Oct;7(10):1031-3. Review.

PMID:
15452573
14.

Federal funding for aging education and research: a decade analysis.

Kerin PB, Estes CL, Douglass EB.

Gerontologist. 1989 Oct;29(5):606-14. Review.

PMID:
2689294
15.
16.

The future of pediatric psychopharmacology.

Walkup JT, Cruz K, Kane S, Geller B.

Pediatr Clin North Am. 1998 Oct;45(5):1265-78. Review.

PMID:
9884685
17.

Controlling the bugs. The first decade in the regulation of biotechnology.

Greenstein RL.

Appl Biochem Biotechnol. 1985 Dec;11(6):489-506. Review.

PMID:
3914236
18.

Trends in biophysical research and their implications for medical libraries.

Chen CC.

Bull Med Libr Assoc. 1973 Apr;61(2):214-24. Review.

19.

Pharmaceutical biotechnology products approved within the European Union.

Walsh G.

Eur J Pharm Biopharm. 2003 Jan;55(1):3-10. Review.

PMID:
12551698
20.

Where will new neuroscience therapies come from?

Schoepp DD.

Nat Rev Drug Discov. 2011 Sep 30;10(10):715-6. doi: 10.1038/nrd3559. Review.

PMID:
21959271
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk